Does CD30 loss preclude the diagnosis of anaplastic lymphoma kinase-positive anaplastic large cell lymphoma? Insights from a rare case
Cytojournal · 22.07.2026 · 23 · 45
DOI: 10.25259/cytojournal_148_2025 ↗Kurz gefasst
Fallbericht in der Zeitschrift Cytojournal, online erschienen am 22.07.2026. Verfasst von Wenjie Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Qingdao University, Qingdao, China. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
CD30 positivity serves as a critical diagnostic hallmark for anaplastic lymphoma kinase positive anaplastic large cell lymphoma (ALK+ ALCL); however, rare cases with partial or complete loss of CD30 expression present diagnostic challenges. We report a unique case with two morphologically and immunophenotypically distinct subpopulations within the same tumor: A typical CD30-positive component and a CD30-negative counterpart. Comparative genetic analysis revealed overlapping but divergent molecular features, including nucleophosmin 1- ALK ( NPM1-ALK ) fusion, notch receptor 1 mutations, and differential gene amplifications involving MYC proto-oncogene and BCL2-like 1. These findings offer insights into the regulatory mechanisms of CD30 and highlight that loss of CD30 expression alone should not preclude the diagnosis of ALK-positive ALCL, underscoring the importance of integrated histopathological and molecular evaluation in diagnostically challenging cases. Meanwhile, it provides a basis for optimizing the diagnostic process of clinically suspected cases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Qingdao University, Qingdao, China.
- Department of Pathology, Affiliated Yantai Yuhuangding Hospital, Qingdao University, Yantai, China.
ORCID-Profile: Guohua Yu
Zitieren
APA
Wang, W., Sui, X., & Yu, G. (2026). Does CD30 loss preclude the diagnosis of anaplastic lymphoma kinase-positive anaplastic large cell lymphoma? Insights from a rare case. Cytojournal, 23, 45. https://doi.org/10.25259/cytojournal_148_2025
Vancouver
Wang W, Sui X, Yu G. Does CD30 loss preclude the diagnosis of anaplastic lymphoma kinase-positive anaplastic large cell lymphoma? Insights from a rare case. Cytojournal. 2026;23:45. doi:10.25259/cytojournal_148_2025
BibTeX
@article{Wang2026,
author = {Wang, Wenjie and Sui, Xiaolong and Yu, Guohua},
title = {Does CD30 loss preclude the diagnosis of anaplastic lymphoma kinase-positive anaplastic large cell lymphoma? Insights from a rare case},
journal = {Cytojournal},
year = {2026},
volume = {23},
pages = {45},
doi = {10.25259/cytojournal_148_2025}
}
EUVIMED